<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>Latest Headlines</title><link>http://rnai.net/index.aspx</link><description></description><language>en-us</language><lastBuildDate>Wednesday, March 10, 2010</lastBuildDate><copyright>Copyright: (C) Technology Networks Ltd</copyright><item><title>Study Identifies Single microRNA Biomarker for Prognosis of Mesothelioma Patients</title><description>Demonstrate potential of miR-29c* to act as an independent prognostic factor for time to progression as well as survival after surgery.</description><link>http://rnai.net/index.aspx?ID=107882</link><link1>http://rnai.net/r/redirect.aspx?contentID=107882&amp;url=http://www.rosettagenomics.com</link1><pubDate>18 February 2010</pubDate></item><item><title>Automating Viral RNA Genotyping</title><description>Agilent Automation Solutions has released a new applications bulletin that describes an automated system for rapid characterization of pathogens, including for example the Influenza A (H1N1) virus.</description><link>http://rnai.net/index.aspx?ID=107868</link><link1>http://rnai.net/r/redirect.aspx?contentID=107868&amp;url=http://www.chem.agilent.com</link1><pubDate>18 February 2010</pubDate></item><item><title>PBL InterferonSource: 20 Years of Interferon Excellence</title><description>Celebrating the 20th anniversary of its expertise in the field of interferons</description><link>http://rnai.net/index.aspx?ID=107893</link><link1>http://rnai.net/r/redirect.aspx?contentID=107893&amp;url=http://www.interferonsource.com</link1><pubDate>18 February 2010</pubDate></item><item><title>FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients</title><description>Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.</description><link>http://rnai.net/index.aspx?ID=107855</link><link1>http://rnai.net/r/redirect.aspx?contentID=107855&amp;url=http://www.quarkpharma.com</link1><pubDate>17 February 2010</pubDate></item><item><title>MDRNA, Inc. Reports Positive Results for its Proprietary siRNA Delivery Technology</title><description>Data demonstrates the potential for long-term stability of drug products.</description><link>http://rnai.net/index.aspx?ID=107628</link><link1>http://rnai.net/r/redirect.aspx?contentID=107628&amp;url=http://www.mdrnainc.com</link1><pubDate>09 February 2010</pubDate></item><item><title>Mirrx Therapeutics Secures Seed Financing for Development of microRNA- blocking Technology</title><description>Finances will enable the company to achieve in vivo proof of concept for its microRNA-blocking Blockmir technology.</description><link>http://rnai.net/index.aspx?ID=107627</link><link1>http://rnai.net/r/redirect.aspx?contentID=107627&amp;url=http://www.mirrx.com</link1><pubDate>09 February 2010</pubDate></item></channel></rss>